Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vanguard Total World Stock Index Fund ETF (VT) vs Zoetis Inc (ZTS) Price & Performance

Vanguard Total World Stock Index Fund ETFTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Vanguard Total World Stock Index Fund ETF vs Zoetis Inc — how do they compare? Vanguard Total World Stock Index Fund ETF trades at $156.27, while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: Zoetis Inc pays a 2.78% dividend while Vanguard Total World Stock Index Fund ETF pays none, and Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.

VTZTS
Sector
Broad Market / FactorHealth
52-Week High
$159.35$156.76
52-Week Low
$128.41$71.91
Market Cap
$31.95B
Enterprise Value
$39.24B
Dividend Yield
2.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Vanguard Total World Stock Index Fund ETF

No Aura AI signal available yet.

Zoetis Inc

Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.

The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Vanguard Total World Stock Index Fund ETF

VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.

Read more on VT

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS